Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Hormones, especially DHT, affect hair loss and growth, and targeting specific enzymes may help treat hair loss.

Microinflammation is more intense in smaller hair follicles and may be linked to hair loss.

Hair stem cells produce a protein called COL17A1 that plays a key role in their development and is linked to hair thinning and baldness.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

UV exposure causes hair thinning, graying, and changes in hair growth cycles in mice.

Mechanical stress contributes to hair loss in androgenetic alopecia.

Androgenetic alopecia affects many people, impacting quality of life, and treatment focuses on reversing hair follicle miniaturization.

Hair loss is caused by the breakdown of a protein called COL17A1 in hair follicle stem cells.

Intense pulsed light treatment effectively reduces underarm hair by making hair follicles smaller and extending their resting phase.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

A tick bite caused temporary hair loss in a man, which is a rare condition that usually gets better within 3 months.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Fibroblasts in hair follicles play a key role in hair loss, suggesting they could be a target for treatment.

SH-1 effectively treats hair loss without side effects.

SH-1 effectively treats hair loss without side effects.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Androgenetic alopecia is common hair loss caused by genetics and hormones, with treatments mainly slowing it down.

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

Finasteride, dutasteride, and oral minoxidil are effective for treating hair loss, with spironolactone as an option for women.